Gout in Focus: Why is it important and how do we achieve better outcomes?
About the podcast
Join Dr Kate Annear as she discusses Gout with Professor Ric Day, a highly experienced rheumatologist and clinical pharmacologist. This podcast will cover why gout is important, and will also address some of the common misconceptions surrounding this condition as well as providing some practical advice on supporting better outcomes in the management of this condition.
Gout is a common, chronic inflammatory type of arthritis that affects 1 in 15 Australians and its prevalence is steadily increasing. But despite effective therapies, research tells us that gout is often undertreated, contributing to significant avoidable pain, disability and impaired quality of life for affected individuals.
In this podcast we will be exploring the potential sequelae of gout, including it’s significant associated comorbidities, in order to understand why it is an important condition to manage well. We will also be addressing common misconceptions in the community and amongst health professionals around gout, including the role of diet and alcohol intake.
We will be discussing the evolution of treatment guidelines for gout, particularly the importance of initiating urate lowering therapy early through a treat-to-target approach with adequate flare prophylaxis. Our discussion extends to strategies aimed at promoting adherence to urate lowering therapy, essential for achieving sustained disease control and minimising disease burden.
Join us to gain a deeper understanding of gout’s complexities and to learn some actionable strategies for better management and improved patient outcomes.
This podcast is brought to you by Medcast and the Quality Use of Medicines Alliance.
For more free Quality Use of Medicines education, check out QHUB on Medcast
Quality Use of Medicines Alliance
Wearables with PPG or ECG capabilities can identify episodes of irregular heart rhythms suggestive of AF, but should not replace traditional methods of diagnosis, such as a 12-lead ECG. Evidence of accuracy and positive predictive values from prospective, comparative trials involving older populations are limited, and the potential for inconclusive results remains a concern based on current trial findings. Their utility may be highest for symptomatic individuals or those at risk of developing AF.
Quality Use of Medicines Alliance
This is the second FastTrack on atrial fibrillation (AF). Part 1 described the diagnosis, initial assessment of AF, and indications for urgent review. This FastTrack describes the approach to setting a management strategy using risk calculators, how to assess and reduce risk factors, and long term monitoring of patients with AF.
Quality Use of Medicines Alliance
Best-practice treatment of depression no longer considers pharmacotherapy as the default first-line therapy for many patients. In this FastTrack activity, you will update your knowledge of evidence-based interventions for major depression, including when to consider medications and when to cease them. Complete the quiz to receive 30mins EA and 30mins RP CPD.